Coexisting dysbetalipoproteinemia and familial hypercholesterolemia: Clinical and laboratory observations

This publication has 32 references indexed in Scilit:

• Impact of a common mutation of the LDL receptor gene, in French‐Canadian patients with familial hypercholesterolemia, on means, variances and correlations among traits of lipid metabolism
  Clinical Genetics, 1995
• Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III
  Atherosclerosis, 1989
• Atherosclerosis of the carotid arteries in young patients with familial hypercholesterolemia
  Journal of Molecular Medicine, 1988
• Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial Hypercholesterolemia
  New England Journal of Medicine, 1987
• Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology.
  Circulation, 1985
• ASSOCIATION OF ISOAPOLIPOPROTEIN-E3 DEFICIENCY WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA: IMPLICATIONS FOR LIPOPROTEIN PHYSIOLOGY
  The Lancet, 1981